Antibody-Drug Conjugates in Prostate Cancer: Where Are we?

Authors : Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T
Year : 2023
Journal : Clin Genitourin Cancer
Volume : 21
Pages : 171-174

Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.

Authors : Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P
Year : 2023
Journal : Prostate
Volume : 83
Pages : 162-168

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.

Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : World J Urol
Volume : 41
Pages : 77-84

Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.

Authors : Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G
Year : 2023
Journal : Eur Urol Open Sci
Volume : 47
Pages : 94-101

Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.

Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : Prostate

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number.

Authors : Albisinni S, Diamand R
Year : 2023
Journal : Prostate Cancer Prostatic Dis

Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.

Authors : Jungels C, Pita JM, Costante G
Year : 2023
Journal : Curr Opin Oncol
Volume : 35
Pages : 1-9

ASO Visual Abstract: Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.

Authors : El Asmar A, Delcourt M, Kamden L, Khaled C, Bohlok A, Moreau M, Sclafani F, Donckier V, Liberale G
Year : 2023
Journal : Ann Surg Oncol
Volume : 30
Pages : 1872-1873

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges.

Authors : Wang X, Collet L, Rediti M, Debien V, De Caluwé A, Venet D, Romano E, Rothé F, Sotiriou C, Buisseret L
Year : 2023
Journal : J Clin Med
Volume : 12

Pre-existing evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.

Authors : Bregni G, Trevisi E, Saude Conde R, Vanhooren M, Akin Telli T, Assaf I, Hendlisz A, Di Maio M, Sclafani F
Year : 2023
Journal : J Natl Cancer Inst

ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value.

Authors : El Asmar A, Liberale G
Year : 2023
Journal : Ann Surg Oncol

European Respiratory Society guideline on various aspects of quality in lung cancer care.

Authors : Blum TG, Morgan RL, Durieux V, Chorostowska-Wynimko J, Baldwin DR, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hardavella G, Hauptmann M, Jakobsen E, Jovanovic D, Knaut P, Massard G, McPhelim J, Meert AP, Milroy R, Muhr R, Mutti L, Paesmans M, Powell P, Putora PM, Rawlinson J, Rich AL, Rigau D, De Ruysscher D, Sculier JP, Schepereel A, Subotic D, van Schil P, Tonia T, Williams C, Berghmans T
Year : 2023
Journal : Eur Respir J
Volume : 61

Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.

Authors : El Asmar A, Delcourt M, Kamden L, Khaled C, Bohlok A, Moreau M, Sclafani F, Donckier V, Liberale G
Year : 2023
Journal : Ann Surg Oncol
Volume : 30
Pages : 1863-1869

The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.

Authors : El Asmar A, Demetter P, Fares F, Sclafani F, Hendlisz A, Donckier V, Vermeulen P, Liberale G
Year : 2023
Journal : Ann Surg Oncol

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.

Authors : Nuciforo P, Townend J, Piccart-Gebhart M, Fielding S, Gkolfi P, El-Abed S, de Azambuja E, Werutsky G, Bliss J, Moebus V, Colleoni M, Aspitia AM, Gomez H, Gombos A, Coccia-Portugal MA, Tseng LM, Kunz G, Lerzo G, Sohn J, Semiglazov V, Saura C, Kroep J, Ferro A, Cameron D, Gelber R, Huober J, Di Cosimo S
Year : 2023
Journal : Eur J Cancer
Volume : 181
Pages : 92-101

Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.

Authors : Lambertini M, Ceppi M, Anderson RA, Cameron DA, Bruzzone M, Franzoi MA, Massarotti C, El-Abed S, Wang Y, Lecocq C, Nuciforo P, Rolyance R, Pusztai L, Sohn J, Latocca MM, Arecco L, Pistilli B, Ruddy KJ, Ballestrero A, Del Mastro L, Peccatori FA, Partridge AH, Saura C, Untch M, Piccart-Gebhart M, Di Cosimo S, de Azambuja E, Demeestere I
Year : 2023
Journal : J Natl Compr Canc Netw
Volume : 21
Pages : 33-41.e16

Medical oncology education in Europe: equipping medical oncologists to provide the best care for patients with cancer.

Authors : Jordan K, de Azambuja E, Amaral T, Strijbos M, Curigliano G, Lordick F
Year : 2023
Journal : Oncol Res Treat

Improving emotion regulation in breast cancer patients in the early survivorship period: Efficacy of a brief ecologically boosted group intervention.

Authors : Merckaert I, Waroquier P, Caillier M, Verkaeren O, Righes S, Liénard A, Libert Y, Kristanto P, Razavi D
Year : 2023
Journal : Psychooncology

Immunotherapy in breast cancer: an overview of current strategies and perspectives.

Authors : Debien V, De Caluwé A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, Buisseret L
Year : 2023
Journal : NPJ Breast Cancer
Volume : 9
Pages : 7

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

Authors : de Azambuja E, Agostinetto E, Procter M, Eiger D, Pondé N, Guillaume S, Parlier D, Lambertini M, Desmet A, Caballero C, Aguila C, Jerusalem G, Walshe JM, Frank E, Bines J, Loibl S, Piccart-Gebhart M, Ewer MS, Dent S, Plummer C, Suter T
Year : 2023
Journal : ESMO Open
Volume : 8
Pages : 100772